These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases]. Lebranchu Y; Despert F; Borderon JC; Bloc D; Renoux M; Bardos P; Laugier J Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169 [No Abstract] [Full Text] [Related]
23. Difficulties in performing clinical trials of antithrombotic therapy in neonates and children. Massicotte MP; Sofronas M; deVeber G Thromb Res; 2006; 118(1):153-63. PubMed ID: 16009401 [TBL] [Abstract][Full Text] [Related]
24. Clinical features of atypical Kawasaki disease. Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122 [TBL] [Abstract][Full Text] [Related]
25. Dermatological aspects of the Kawasaki syndrome (mucocutaneous lymph node syndrome, MCLS). Doerfer J; Wässer S Dermatol Monatsschr; 1986; 172(4):212-6. PubMed ID: 3721027 [No Abstract] [Full Text] [Related]
26. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology]. Cachin Y; Flamant R; Richard J; Sancho-Garnier H Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330 [No Abstract] [Full Text] [Related]
27. Statistical methods in clinical trials. Gebski VJ; Keech AC Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749 [No Abstract] [Full Text] [Related]